According to Psychemedics's latest financial reports the company's current EPS (TTM) is -$0.19. In 2021 the company made an earnings per share (EPS) of -$0.13 an increase over its 2020 EPS that were of -$0.70.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$0.19 | 46.97% |
2021 | -$0.13 | -81.37% |
2020 | -$0.70 | -349.57% |
2019 | $0.28 | -66.42% |
2018 | $0.83 | -25.48% |
2017 | $1.12 | -8.97% |
2016 | $1.23 | 338.57% |
2015 | $0.28 | -53.33% |
2014 | $0.60 | -16.67% |
2013 | $0.72 | 26.32% |
2012 | $0.57 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | $8.06 | -4,317.58% | ๐บ๐ธ USA |
![]() LabCorp LH | $11.07 | -5,892.63% | ๐บ๐ธ USA |
![]() RadNet RDNT | $0.18 | -194.19% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -$1.01 | 428.51% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZ | -$0.60 | 213.96% | ๐บ๐ธ USA |